Spero Therapeutics Inc (SPRO) - Dodolan perusahaan

How do ESG standards and the fight against superbugs impact the revenue of Spero Therapeutics (SPRO)? The company's operating sales reflect the dynamics of this process, where 0.04 represents the latest metric reading. High cold chain costs for drug delivery increase logistics expenses, while tight clinic budgets and reliance on government procurement limit the issuer's pricing power.

SPRO: Pendapatan lan volume dodolan Spero Therapeutics 04.07.2022 - 14.11.2026

Rincian analitis perusahaan Spero Therapeutics

- rega pasar lan target rega analis:

Rega bursa Spero Pharma|SPRO - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Biji pasar Spero Therapeutics, Inc.|SPRO - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Rega Buku Saham Spero Therapeutics|SPRO - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku sperotherapeutics.com|SPRO - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang marang Modal Spero Therapeutics|SPRO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Spero Therapeutics Inc|SPRO - Utang perusahaan|Utang-utang marang aset resik Spero Therapeutics, Inc.|SPRO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Spero Therapeutics|Rasio likuiditas kritis sperotherapeutics.com

- informasi bathi lan kelipatan valuasi:

SPRO - Bathi resik|Bathi resik sing dikarepake Spero Therapeutics|SPRO - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi sperotherapeutics.com|SPRO - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Spero Therapeutics, Inc.|SPRO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Spero Therapeutics|SPRO - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sperotherapeutics.com|SPRO - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Spero Therapeutics

- statistik dodolan lan pendapatan perusahaan:

SPRO - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan Spero Pharma|SPRO - Rasio rega marang pendapatan|Rega forward marang dodolan Spero Therapeutics, Inc.

Analisis komprehensif perusahaan:Spero Therapeutics

Spero Therapeutics (SPRO) develops critical antibiotics within a stable US regulatory environment shielded from geopolitical risks. The dynamics of this process are reflected in the total daily transactions that form the current cash flow. This indicator measures the issuer's operational capacity to generate revenue in real time. By analyzing the company's gross sales volume, an investor can promptly identify a shift in the operational trend and assess the sustainability of market demand.

Analisis perusahaan pesaing

Total pendapatan perusahaan Summit Pharma SMMT|Pendapatan lan volume dodolan MRNA|Dodolan perusahaan vaxcyte.com PCVX|Tarsus Pharmaceuticals, Inc. - Dodolan perusahaan|Total dodolan perusahaan CRMD (CorMedix Inc)|Seres - Pendapatan lan volume dodolan|Pendapatan reged perusahaan SCYNEXIS, Inc. SCYX|an2therapeutics.com (ANTX) - Pendapatan perusahaan|Total pendapatan perusahaan PolyPid (PYPD)|Pendapatan perusahaan LakeShore Biopharma|Volume dodolan perusahaan ITRM (Iterum Therapeutics, plc)|Pendapatan perusahaan BiomX Inc. (PHGE)|Pendapatan reged perusahaan soligenix.com|Pendapatan perusahaan 60 Degrees Pharmaceuticals, Inc. SXTP|Pendapatan reged perusahaan Oragenics Inc. (OGEN)|OPGN - Pendapatan perusahaan